• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxamides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxamides

Introduction to 2-Hydroxypyridine-3-carboxamide (CAS No. 94083-12-2)

2-Hydroxypyridine-3-carboxamide, identified by the Chemical Abstracts Service Number (CAS No.) 94083-12-2, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic amide derivative features a pyridine core substituted with both a hydroxyl group at the 2-position and an amide functionality at the 3-position. Its unique structural motifs make it a valuable intermediate in the development of novel therapeutic agents, particularly in the areas of anticancer, anti-inflammatory, and antimicrobial drug discovery.

The structure of 2-hydroxypyridine-3-carboxamide contributes to its versatility as a synthetic scaffold. The presence of both electron-donating and electron-withdrawing groups allows for diverse chemical modifications, enabling chemists to tailor its properties for specific biological targets. This adaptability has been exploited in recent years to develop molecules with enhanced pharmacokinetic profiles and improved therapeutic efficacy.

Recent advancements in medicinal chemistry have highlighted the potential of pyridine derivatives as key components in drug design. Among these, 2-hydroxypyridine-3-carboxamide has garnered attention due to its ability to interact with biological macromolecules in a manner conducive to therapeutic intervention. For instance, studies have demonstrated its utility as a precursor in the synthesis of kinase inhibitors, which are critical in treating various forms of cancer.

In particular, research has focused on leveraging the hydroxyl and amide functional groups of this compound to modulate protein-protein interactions or enzyme activity. The hydroxyl group can participate in hydrogen bonding networks, enhancing binding affinity to target proteins, while the amide moiety serves as a site for further derivatization via coupling reactions such as amide bond formation or condensation reactions. These features make it an attractive building block for structure-based drug design.

One notable application of 2-hydroxypyridine-3-carboxamide is in the development of small-molecule inhibitors targeting pathogenic enzymes. For example, modifications to this scaffold have yielded compounds with inhibitory activity against Janus kinases (JAKs), which play a pivotal role in inflammatory signaling pathways. Such inhibitors are being explored for their potential in treating autoimmune diseases like rheumatoid arthritis and psoriasis.

The synthesis of 2-hydroxypyridine-3-carboxamide typically involves multi-step organic transformations, often starting from commercially available pyridine derivatives. Common synthetic routes include nucleophilic substitution reactions to introduce the hydroxyl group, followed by carboxylation or amidation steps to install the amide functionality. Advances in catalytic methods have enabled more efficient and sustainable synthetic pathways, reducing waste and improving yields.

From a computational chemistry perspective, 2-hydroxypyridine-3-carboxamide has been subjected to extensive molecular modeling studies to elucidate its interactions with biological targets. These studies have provided insights into how structural variations influence binding affinity and selectivity. For instance, computational analyses have identified key residues on target proteins that mediate binding interactions with this compound's core scaffold.

The pharmacological profile of derivatives of 2-hydroxypyridine-3-carboxamide has been extensively evaluated in preclinical models. Preclinical studies have demonstrated that certain analogs exhibit potent activity against tumor cell lines while maintaining low toxicity toward healthy cells. This selectivity is attributed to subtle differences in electronic distribution and steric hindrance within the molecule, which can be fine-tuned through structural optimization.

In conclusion, 2-hydroxypyridine-3-carboxamide (CAS No. 94083-12-2) represents a promising scaffold for drug discovery efforts aimed at addressing unmet medical needs. Its unique structural features and synthetic accessibility make it an invaluable tool for medicinal chemists seeking to develop novel therapeutic agents with improved efficacy and safety profiles. As research continues to uncover new biological targets and mechanistic insights, compounds derived from this scaffold are poised to play a significant role in future pharmacological interventions.

• 3670-59-5(6-Hydroxynicotinamide)
• 35441-11-3(3-Pyridinecarboxamide,1,2-dihydro-6-hydroxy-2-oxo-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)